- About About
Medical Patient Resources Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Leaf411 Affordability Program Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- News News
- Join Join
Washington, DC- On October 8th, 2015 the Division of Chemical Health and Safety (CHAS) of the American Chemical Society voted to form the Cannabis Chemistry Subdivision (CANN). The CANN subdivision previously existed under the Small Chemical Business Division as the Cannabis Chemistry Committee, but will be located within CHAS following the expansion to official subdivision status. CHAS provides expertise in laboratory safety, chemical management and chemical safety practices. The committee’s decision to form an official subdivision comes in response to substantial growth in the medical and commercial cannabis industries in recent years.
“The membership of the American Chemical Society deserves praise for recognizing the need for scientific leadership on cannabis,” said Jahan Marcu, Americans for Safe Access (ASA) senior scientist and CANN subdivision vice chair. “We were told the process of becoming an official subdivision might take years, but the amazing response from members that recognized the importance of this work made the process much faster.”
The CANN subdvision is comprised of experts with over 100 years of experience in cannabis chemistry, research and industry regulation. The CANN subdivision will focus on networking, encouraging the development of professional relationships, provide a symposium for research and facilitate the development and use of best practices. Since 2011, the number of cannabis testing laboratories has grown from two to more then two dozen, in some instances these laboratories are tasked with performing testing required by state law.
“The cannabis industry needs highly trained chemists and job seeking chemists need to know about new opportunities,” said Ezra Pryor, CANN subdivision chair and President of EZ Chem Consultancy Inc. “We have the opportunity to recognize those that are taking every effort to be ethical and compliant while also informing those who are not. We can also educate the general public and illustrate how consumer awareness can drive best industry practices. I’d like to thank Americans for Safe Access for supporting this important work.”
ASA has previously worked with the American Herbal Products Association (AHPA) to create standards for cannabis cultivation, manufacturing, distribution and laboratory analysis. In 2013, ASA also worked with the American Herbal Pharmacopoeia to create the cannabis monograph, which created the first scientifically valid standards for companies engaged in laboratory analysis of cannabis, cannabis-derived products and hemp products. AHPA’s cannabis standards have been included in regulations in over a dozen state medical cannabis laws including, Alaska, Florida, New York, Illinois, Maryland, Nevada, Washington, Oregon, Massachusetts, Minnesota, Hawaii, Colorado and California’s recently passed regulatory law.
“The CANN subdivision represents another important milestone in the professionalization of cannabis science,” said Steph Sherer, ASA’s executive director. “ASA has worked to fill the void in cannabis science left by federal inaction with the APHA cannabis standards and the cannabis monograph, the approval of CANN allows us to work with America’s top chemists to promote the harmonization cannabis laboratory regulations and create effective and precise standards so that patients can have confidence in their medicine. ”
The American Chemical Society is the largest scientific society in the world and has over 150,000 professional members.